Literature DB >> 31146266

About the Marty model of blood-brain barrier closure after its disruption using focused ultrasound.

Allegra Conti1, Sébastien Mériaux, Benoit Larrat.   

Abstract

Many studies have demonstrated that pulsed ultrasound combined with circulating microbubbles can permeate the blood-brain barrier in a reversible manner. In 2012, our group demonstrated that the BBB remains permeable to small MRI contrast agents up to 24 h after ultrasound application and also that this duration was dependent on nanoparticle size. We derived a simple theoretical model explaining these observations (Marty et al 2012 J. Cereb. Blood Flow Metab. 32 1948-58). However, in this original paper the expression of the BBB closure time (t 1/2) as a function of the size of delivered contrast agents (d H) could not be mathematically derived from the model but rather from a guessed function that is fit to the numerical solution of the model. In this context, the two numeric parameters of this fitting function could not be related to the other physical parameters of the model. Here, we present a formal solution, finding the same expression of t 1/2 already published and linking t 1/2 to relevant physical variables such as the molecular hydrodynamic diameter d H, the BBB closure rate k and the standard deviation of the initial BBB gap sizes distribution σ 0.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31146266     DOI: 10.1088/1361-6560/ab259d

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

Review 1.  Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier.

Authors:  Nick Todd; Cleide Angolano; Christiane Ferran; Anna Devor; David Borsook; Nathan McDannold
Journal:  J Control Release       Date:  2020-05-26       Impact factor: 11.467

Review 2.  Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?

Authors:  Alessandro Stefani; Mariangela Pierantozzi; Silvia Cardarelli; Lucrezia Stefani; Rocco Cerroni; Matteo Conti; Elena Garasto; Nicola B Mercuri; Carmine Marini; Patrizia Sucapane
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

Review 3.  Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers.

Authors:  Mirna Lechpammer; Rohan Rao; Sanjit Shah; Mona Mirheydari; Debanjan Bhattacharya; Abigail Koehler; Donatien Kamdem Toukam; Kevin J Haworth; Daniel Pomeranz Krummel; Soma Sengupta
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

4.  Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption.

Authors:  Charlotte Bérard; Stéphane Desgranges; Noé Dumas; Anthony Novell; Benoit Larrat; Mourad Hamimed; Nicolas Taulier; Marie-Anne Estève; Florian Correard; Christiane Contino-Pépin
Journal:  Pharmaceutics       Date:  2022-07-19       Impact factor: 6.525

Review 5.  Breaching the Blood-Brain Tumor Barrier for Tumor Therapy.

Authors:  Fabrizio Marcucci; Angelo Corti; Andrés J M Ferreri
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

6.  Empirical and Theoretical Characterization of the Diffusion Process of Different Gadolinium-Based Nanoparticles within the Brain Tissue after Ultrasound-Induced Permeabilization of the Blood-Brain Barrier.

Authors:  Allegra Conti; Rémi Magnin; Matthieu Gerstenmayer; Nicolas Tsapis; Erik Dumont; Olivier Tillement; François Lux; Denis Le Bihan; Sébastien Mériaux; Stefania Della Penna; Benoit Larrat
Journal:  Contrast Media Mol Imaging       Date:  2019-12-01       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.